2 Excellent Dividend Stocks to Buy on the Dip [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
They are both leading drugmakers and have strong dividend track records. Both also recently saw their shares fall significantly in one day, following unimpressive clinical data for otherwise promising candidates. Despite their recent setbacks, these healthcare giants remain attractive income stocks, especially for investors willing to be patient. Here's why. 1. AbbVie Sometimes acquisitions create value for all those involved. Sometimes they don't, as AbbVie is finding out the hard way. The company's $8.7 billion buyout of Cerevel Therapeutics now looks like a waste of money after the leading asset it got from that transaction, emraclidine, failed a pair of phase 2 studies. Since that debacle, AbbVie's shares are down by 13%: ABBV data by YCharts However, the company is still active in mergers and acquisitions, and is already on the offensive. Recently AbbVie closed its acquisition of Aliada Therapeutics, including a promising Alzheimer's disease candidate, for $1.4 billion
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- South Korea Baby Food Market Assessment and Forecasts to 2029: Deceleration in South Korea's Birth Rates Influences Baby Food Sector Dynamics [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories' (NYSE:ABT) investors will be pleased with their respectable 43% return over the last five years [Yahoo! Finance]Yahoo! Finance
- Cardiac Marker Tests Pipeline Report Featuring 230+ Companies and Prospective Products by Stages of Development, Segments, Region and Countries, Regulatory Path [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website